Finance

Lists
Why is 4564 down 4,76%?
Dive Deeper
4564:TYO
OncoTherapy Science, Inc.
20,00 JP¥
-4,76%
(-1,00) 1D
7 հոկ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4564...
Open
21 JP¥
High
21 JP¥
Low
20 JP¥
Mkt. cap
8,16 մլրդ
Avg. vol.
170,89 մլն
Volume
252,11 մլն
52-wk high
34 JP¥
52-wk low
18 JP¥
EPS
-2 JP¥
Shares outstanding
147,03 մլն
No. of employees
46
Open
21 JP¥
High
21 JP¥
Low
20 JP¥
Mkt. cap
8,16 մլրդ
Avg. vol.
170,89 մլն
Volume
252,11 մլն
52-wk high
34 JP¥
52-wk low
18 JP¥
EPS
-2 JP¥
Shares outstanding
147,03 մլն
No. of employees
46
News stories
From web sources and news partners
About OncoTherapy Science, Inc.
CEO-
Employees46
Founded06 ապր, 2001 թ.
Headquarters-
Sector-
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
230,00 մլն
166,00 մլն
211,00 մլն
170,00 մլն
Cost of goods sold
301,00 մլն
278,00 մլն
362,00 մլն
335,00 մլն
Cost of revenue
301,00 մլն
278,00 մլն
362,00 մլն
335,00 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
101,00 մլն
107,00 մլն
-36,00 մլն
120,00 մլն
Operating expense
101,00 մլն
107,00 մլն
-36,00 մլն
120,00 մլն
Total operating expenses
402,00 մլն
385,00 մլն
326,00 մլն
455,00 մլն
Operating income
-172,00 մլն
-219,00 մլն
-115,00 մլն
-285,00 մլն
Other non operating income
-7,00 մլն
-6,00 մլն
-8,00 մլն
-1,00 մլն
EBT including unusual items
-240,00 մլն
-228,00 մլն
-126,00 մլն
-288,00 մլն
EBT excluding unusual items
-180,00 մլն
-226,00 մլն
-125,00 մլն
-287,00 մլն
Income tax expense
1,00 մլն
-
1,00 մլն
-
Effective tax rate
-0,42%
-
-0,79%
-
Other operating expenses
-
-
-
-
Net income
-241,00 մլն
-228,00 մլն
-127,00 մլն
-288,00 մլն
Net profit margin
-104,78%
-137,35%
-60,19%
-169,41%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-1,00 մլն
-
Net interest expenses
-
-
-1,00 մլն
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps